Bankruptcy Litigation

Haynes and Boone’s Restructuring Group is uniquely qualified to handle cases where complex litigation and insolvency proceedings intersect. Our attorneys have decades of experience litigating insolvency-related issues in federal bankruptcy, district and circuit courts nationwide. Our bankruptcy litigators are real trial lawyers who know how and when to use litigation to get results in complex restructurings. We represent parties in all aspects of this type of litigation: debtors, secured lenders, unsecured creditors, official and ad hoc committees, private equity funds, litigation trustees, transferees in fraudulent transfer and preference litigation, director and officer and successor liability litigation, lien challenge litigation, contested confirmation and claim objection proceedings, asset sales, and bankruptcy appeals. Our attorneys are also experienced in the short fuse litigation that often arises in this context, be it temporary injunction and contempt proceedings, or matters implicating expedited discovery and discovery disputes. In complex insolvency-related litigation and appellate matters, our restructuring attorneys often draw upon the vast resources of the firm’s litigation and appellate practice groups, and also bring to bear experience in the range of specialized areas that can be implicated in insolvency and bankruptcy centered litigation. Our team is thoroughly prepared to take on insolvency litigation of any size and scope across the United States, and take a business oriented approach where the client’s costs and benefits are taken into consideration at every stage of the proceedings.

Show More
Article/Mention
Hughes in The Washington Post: Supreme Court Opioid Case Makes It Harder to Shield Wealth in Bankrup [...]
July 01, 2024

Haynes and Boone, LLP Partner Patrick Hughes was featured in an article from The Washington Post as companies seeking protection from lawsuits by filing for bankruptcy must now reckon with a Supreme Court ruling against the opioid company Purdue Pharma that substantially raised the bar for executives and owners trying to shield their wealth. Notably, the Supreme Court’s opinion on Purdue pointed t [...]